Gilead Welcomes You to ID Week 2020 We are honored to join the leading voices in HIV as we gather virtually for ID Week 2020.

Idweek 2020. At IDWeek you will see familiar colleagues and new facesIDWeek is a forum for health professionals of. IDWeek is the joint annual meeting of the Infectious Diseases Society of America IDSA Society for Healthcare Epidemiology of America SHEA the HIV. Save sessions and appointments to a personalized calendar Save time with exhibitor and product recommendations.

Virtual Event Healix is a proud exhibitor at ID Week TM 2020. 2020 IDWeek October 21-25 2020. For more than 30 years weve been working to help put an end to the HIV epidemic pursuing innovations in HIV treatment and prevention.

New data may evidence oral care as a therapeutic measure to reduce bacterial and viral spread. Eight AWG member companies will present data from their clinical and research programs at the virtual IDWeek 2020 held October 21-25 with a total of 26 ePosters and 6 on-demand oral abstracts. The annual IDWeek conference was held virtually for the first time on Oct 2125 2020.

Medscape Medical News November 19 2020. Virtual Conference Get the latest data on a range of COVID-19 topics with a downloadable slideset and on-demand audio as well as new data on HIV management with expert commentaries all covering key studies from this important annual conference. It featured notable speakers from the Infectious Diseases Society of America Society for Healthcare Epidemiology of America the HIV Medical Association the Pediatric Infectious Diseases Society and the Society of Infectious Diseases Pharmacists.

October 25 2020. Aging With HIV Adds to Comorbidity Burden. Oral Care to Reduce Hospital Infections.

Gandhi MD on some of the most important COVID-19 data reported at the virtual IDWeek 2020 conference including new findings on transmission in different settings symptom progression and clinical outcomes detection of non-SARS-CoV-2 viruses during the pandemic and treatment and prevention strategies. AWG Member Company Participation at IDWeek 2020. The presenting IDWeek author discusses the implication of promising phase 3 data for a new HBV vaccine.